Baltimore (1)

Boston (1)

Columbus (1)

IDH1 Mutation Myeloid Neoplasms (1)

Active, not recruiting (1)

phase 1 (1)

Massachusetts General Hospital (1)

Agios Pharmaceuticals, Inc. (1)

ivosidenib (1)

drug (1)

Other (1)

Interventional (1)

idh1 mutation myeloid neoplasms

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Oct 25, 2021